TCL Archive ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer May 30, 2014
TCL Archive In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says February 12, 1999
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002